CHAIR
(S):
SPEAKER
(S):
Lawrence Goldstein, PhD, Investigator, Howard Hughes Medical Institute (HHMI) , Professor, Department of Cellular and Molecular Medicine (CMM) and DIrector, UC San Diego Stem Cell Program , University of California San Diego
Jeff Karan, MBA, Senior Partner , Proteus Venture Partners
Janet Rossant, PhD, FRS, FRSC, Chief of Research and Senior Scientist, The Hospital for Sick Children, and University Professor , University of Toronto
Alan Trounson, PhD, President , California Institute for Regenerative Medicine
Description
"Progress on Proposition 71, the California Stem Cell Initiative, will be discussed with an emphasis on technology transfer, funding and company formation. The central theme of this panel will be that Proposition 71 has provided a significant boost not only in funding research, but also in encouraging and fueling the creation of stem cell companies in California."
Objective1:Present a perspective from the CA Institute for Regenerative Medicine on the status of the initiative as of June 2008.
Objective2:Present the perspective of academic and private research on how the initiative has contributed to the progress in basic research.
Objective3:Present perspectives from new stem cell companies on how the act has helped in company formation.